Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Revenue (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Revenue for 5 consecutive years, with -$302000.0 as the latest value for Q2 2025.

  • Quarterly Revenue rose 24.69% to -$302000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$649000.0 through Dec 2025, up 18.98% year-over-year, with the annual reading at $7.0 million for FY2023, N/A changed from the prior year.
  • Revenue hit -$302000.0 in Q2 2025 for Kezar Life Sciences, up from -$347000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $7.0 million in Q3 2023 to a low of -$401000.0 in Q2 2024.
  • Historically, Revenue has averaged $411000.0 across 5 years, with a median of -$324500.0 in 2025.
  • Biggest five-year swings in Revenue: crashed 45.67% in 2023 and later rose 24.69% in 2025.
  • Year by year, Revenue stood at -$159000.0 in 2021, then plummeted by 71.07% to -$272000.0 in 2022, then skyrocketed by 2673.53% to $7.0 million in 2023, then plummeted by 105.73% to -$401000.0 in 2024, then increased by 24.69% to -$302000.0 in 2025.
  • Business Quant data shows Revenue for KZR at -$302000.0 in Q2 2025, -$347000.0 in Q1 2025, and -$401000.0 in Q2 2024.